Rapid clonidine withdrawal with blood pressure overshoot exaggerated by beta-blockade.
作者信息
Bailey R R, Neale T J
出版信息
Br Med J. 1976 Apr 17;1(6015):942-3. doi: 10.1136/bmj.1.6015.942-a.
Abstract
摘要
相似文献
1
Rapid clonidine withdrawal with blood pressure overshoot exaggerated by beta-blockade.
Br Med J. 1976 Apr 17;1(6015):942-3. doi: 10.1136/bmj.1.6015.942-a.
2
Aggravation of the severity of the clonidine withdrawal syndrome in conscious rats by beta 2-adrenoceptor antagonists.
Drugs. 1990;40 Suppl 4:45-7. doi: 10.2165/00003495-199000404-00012.
3
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Drugs. 1984;28 Suppl 2:51-68. doi: 10.2165/00003495-198400282-00005.
4
Rebound hypertension after discontinuation of transdermal clonidine therapy.
Am J Med. 1987 Jan;82(1):17-9. doi: 10.1016/0002-9343(87)90371-8.
5
[Hypertensive crisis after withdrawal of clonidine and nadolol. Case report and review of the literature].
Schweiz Med Wochenschr. 1987 Jun 6;117(23):874-8.
6
Withdrawal of antihypertensive therapy. Hypertensive crisis in renovascular hypertension.
JAMA. 1977 Oct 17;238(16):1734-6.
7
Abrupt discontinuation of clonidine therapy.
JAMA. 1979 Nov 9;242(19):2104-5.
8
Beta 2-adrenoceptor antagonists intensify clonidine withdrawal syndrome in conscious rats.
J Cardiovasc Pharmacol. 1989 Dec;14(6):886-91. doi: 10.1097/00005344-198912000-00015.
9
Effects of clonidine withdrawal: possible mechanisms and suggestions for management.
Br Med J. 1973 Apr 28;2(5860):209-11. doi: 10.1136/bmj.2.5860.209.
10
Rebound hypertension and withdrawal associated with discontinuation of an infusion of epidural clonidine.
Anesthesiology. 1996 Mar;84(3):729-31. doi: 10.1097/00000542-199603000-00031.
引用本文的文献
1
Drug-related Problems in Hypertensive Patients: A Cross-sectional Study from Indonesia.
J Res Pharm Pract. 2020 Oct 8;9(3):140-145. doi: 10.4103/jrpp.JRPP_20_16. eCollection 2020 Jul-Sep.
2
Clonidine withdrawal induced sympathetic surge.
BMJ Case Rep. 2015 Jun 2;2015:bcr2015210325. doi: 10.1136/bcr-2015-210325.
3
Guanfacine and guanfacine extended release: treatment for ADHD and related disorders.
CNS Drug Rev. 2007 Winter;13(4):465-74. doi: 10.1111/j.1527-3458.2007.00026.x.
4
Potentially significant drug interactions of class III antiarrhythmic drugs.
Drug Saf. 2003;26(6):421-38. doi: 10.2165/00002018-200326060-00004.
5
Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder.
Clin Pharmacokinet. 2001;40(10):753-72. doi: 10.2165/00003088-200140100-00004.
6
The implications of noncompliance with antihypertensive medication.
Drugs. 1996 Aug;52(2):186-95. doi: 10.2165/00003495-199652020-00003.
7
beta-blockers. Drug interactions of clinical significance.
Drug Saf. 1995 Dec;13(6):359-70. doi: 10.2165/00002018-199513060-00005.
8
Changes in blood pressure, heart rate, and sympathetic activity on abrupt withdrawal of tiamenidine (HOE 440) in essential hypertension.
Eur J Clin Pharmacol. 1980 Nov;18(6):449-54. doi: 10.1007/BF00874654.
9
Use of labetalol in hypertensive patients during discontinuation of clonidine therapy.
Eur J Clin Pharmacol. 1981;20(4):237-40. doi: 10.1007/BF00618771.
10
Drug interactions and beta blockers.
Br Med J (Clin Res Ed). 1984 Nov 17;289(6455):1330-1. doi: 10.1136/bmj.289.6455.1330.
本文引用的文献
1
Effects of clonidine withdrawal: possible mechanisms and suggestions for management.
Br Med J. 1973 Apr 28;2(5860):209-11. doi: 10.1136/bmj.2.5860.209.
Zotero 插件